newsfilter
← Latest News
PR Newswire·

Kintara Therapeutics to Present at the 2023 BIO CEO & Investor Conference

SAN DIEGO, Jan. 30, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies,